LAS VEGAS, NV / ACCESSWIRE / September 3, 2021 / Virtual Medical International, Inc. (OTC:QEBR), a wellness company in the hemp-derived CBD sector, today announced four new appointees to its Board Of Directors....
MYCO Continues to Strengthen Board of Directors in Anticipation of Senior Exchange Listing Requirements
Company files seven provisional patent applications with United States Patent and Trademark Office
DENVER, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed...
DENVER, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...
Leading FDA consultancy firm to advise on drug development and clinical trial pipeline
The first Mydecine Speaker Series event will feature Mydecine Scientific Advisory Board Members Dr. Robin Carhart -Harris and Dr. Ruth Lanius , Chief Medical Officer Rakesh Jetly and...
Mydecine completes harvest and is preparing to export 20 kilograms of psilocybin mushrooms from Jamaica to Canada for increased global supply scale of cGMP nature-sourced psilocybin
VANCOUVER, British Columbia, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (the “ Company ”) (CSE:MYCO | OTC:MYCOF) announces that its previously issued financial statements for...
Dr. Rakesh Jetly Appointed Chief Medical Officer